Apoptosis induced by piroxicam plus cisplatin combined treatment is triggered by p21 in mesothelioma.

<h4>Background</h4>Malignant mesothelioma (MM) is a rare, highly aggressive tumor, associated to asbestos exposure. To date no chemotherapy regimen for MM has proven to be definitively curative, and new therapies for MM treatment need to be developed. We have previously shown in vivo tha...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Alfonso Baldi, Maria Teresa Piccolo, Maria Rosaria Boccellino, Aldo Donizetti, Irene Cardillo, Raffaele La Porta, Lucio Quagliuolo, Enrico P Spugnini, Francesca Cordero, Gennaro Citro, Massimo Menegozzo, Raffaele A Calogero, Stefania Crispi
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2011
Materias:
R
Q
Acceso en línea:https://doaj.org/article/acef1d49b26b4ff8a14a7824a0ed1cc5
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:acef1d49b26b4ff8a14a7824a0ed1cc5
record_format dspace
spelling oai:doaj.org-article:acef1d49b26b4ff8a14a7824a0ed1cc52021-11-18T06:47:46ZApoptosis induced by piroxicam plus cisplatin combined treatment is triggered by p21 in mesothelioma.1932-620310.1371/journal.pone.0023569https://doaj.org/article/acef1d49b26b4ff8a14a7824a0ed1cc52011-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21858171/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Malignant mesothelioma (MM) is a rare, highly aggressive tumor, associated to asbestos exposure. To date no chemotherapy regimen for MM has proven to be definitively curative, and new therapies for MM treatment need to be developed. We have previously shown in vivo that piroxicam/cisplatin combined treatment in MM, specifically acts on cell cycle regulation triggering apoptosis, with survival increase.<h4>Methodology/principal findings</h4>We analyzed, at molecular level, the apoptotic increase caused by piroxicam/cisplatin treatment in MM cell lines. By means of genome wide analyses, we analyzed transcriptional gene deregulation both after the single piroxicam or cisplatin and the combined treatment. Here we show that apoptotic increase following combined treatment is mediated by p21, since apoptotic increase in piroxicam/cisplatin combined treatment is abolished upon p21 silencing.<h4>Conclusions/significance</h4>Piroxicam/cisplatin combined treatment determines an apoptosis increase in MM cells, which is dependent on the p21 expression. The results provided suggest that piroxicam/cisplatin combination might be tested in clinical settings in tumor specimens that express p21.Alfonso BaldiMaria Teresa PiccoloMaria Rosaria BoccellinoAldo DonizettiIrene CardilloRaffaele La PortaLucio QuagliuoloEnrico P SpugniniFrancesca CorderoGennaro CitroMassimo MenegozzoRaffaele A CalogeroStefania CrispiPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 6, Iss 8, p e23569 (2011)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Alfonso Baldi
Maria Teresa Piccolo
Maria Rosaria Boccellino
Aldo Donizetti
Irene Cardillo
Raffaele La Porta
Lucio Quagliuolo
Enrico P Spugnini
Francesca Cordero
Gennaro Citro
Massimo Menegozzo
Raffaele A Calogero
Stefania Crispi
Apoptosis induced by piroxicam plus cisplatin combined treatment is triggered by p21 in mesothelioma.
description <h4>Background</h4>Malignant mesothelioma (MM) is a rare, highly aggressive tumor, associated to asbestos exposure. To date no chemotherapy regimen for MM has proven to be definitively curative, and new therapies for MM treatment need to be developed. We have previously shown in vivo that piroxicam/cisplatin combined treatment in MM, specifically acts on cell cycle regulation triggering apoptosis, with survival increase.<h4>Methodology/principal findings</h4>We analyzed, at molecular level, the apoptotic increase caused by piroxicam/cisplatin treatment in MM cell lines. By means of genome wide analyses, we analyzed transcriptional gene deregulation both after the single piroxicam or cisplatin and the combined treatment. Here we show that apoptotic increase following combined treatment is mediated by p21, since apoptotic increase in piroxicam/cisplatin combined treatment is abolished upon p21 silencing.<h4>Conclusions/significance</h4>Piroxicam/cisplatin combined treatment determines an apoptosis increase in MM cells, which is dependent on the p21 expression. The results provided suggest that piroxicam/cisplatin combination might be tested in clinical settings in tumor specimens that express p21.
format article
author Alfonso Baldi
Maria Teresa Piccolo
Maria Rosaria Boccellino
Aldo Donizetti
Irene Cardillo
Raffaele La Porta
Lucio Quagliuolo
Enrico P Spugnini
Francesca Cordero
Gennaro Citro
Massimo Menegozzo
Raffaele A Calogero
Stefania Crispi
author_facet Alfonso Baldi
Maria Teresa Piccolo
Maria Rosaria Boccellino
Aldo Donizetti
Irene Cardillo
Raffaele La Porta
Lucio Quagliuolo
Enrico P Spugnini
Francesca Cordero
Gennaro Citro
Massimo Menegozzo
Raffaele A Calogero
Stefania Crispi
author_sort Alfonso Baldi
title Apoptosis induced by piroxicam plus cisplatin combined treatment is triggered by p21 in mesothelioma.
title_short Apoptosis induced by piroxicam plus cisplatin combined treatment is triggered by p21 in mesothelioma.
title_full Apoptosis induced by piroxicam plus cisplatin combined treatment is triggered by p21 in mesothelioma.
title_fullStr Apoptosis induced by piroxicam plus cisplatin combined treatment is triggered by p21 in mesothelioma.
title_full_unstemmed Apoptosis induced by piroxicam plus cisplatin combined treatment is triggered by p21 in mesothelioma.
title_sort apoptosis induced by piroxicam plus cisplatin combined treatment is triggered by p21 in mesothelioma.
publisher Public Library of Science (PLoS)
publishDate 2011
url https://doaj.org/article/acef1d49b26b4ff8a14a7824a0ed1cc5
work_keys_str_mv AT alfonsobaldi apoptosisinducedbypiroxicampluscisplatincombinedtreatmentistriggeredbyp21inmesothelioma
AT mariateresapiccolo apoptosisinducedbypiroxicampluscisplatincombinedtreatmentistriggeredbyp21inmesothelioma
AT mariarosariaboccellino apoptosisinducedbypiroxicampluscisplatincombinedtreatmentistriggeredbyp21inmesothelioma
AT aldodonizetti apoptosisinducedbypiroxicampluscisplatincombinedtreatmentistriggeredbyp21inmesothelioma
AT irenecardillo apoptosisinducedbypiroxicampluscisplatincombinedtreatmentistriggeredbyp21inmesothelioma
AT raffaelelaporta apoptosisinducedbypiroxicampluscisplatincombinedtreatmentistriggeredbyp21inmesothelioma
AT lucioquagliuolo apoptosisinducedbypiroxicampluscisplatincombinedtreatmentistriggeredbyp21inmesothelioma
AT enricopspugnini apoptosisinducedbypiroxicampluscisplatincombinedtreatmentistriggeredbyp21inmesothelioma
AT francescacordero apoptosisinducedbypiroxicampluscisplatincombinedtreatmentistriggeredbyp21inmesothelioma
AT gennarocitro apoptosisinducedbypiroxicampluscisplatincombinedtreatmentistriggeredbyp21inmesothelioma
AT massimomenegozzo apoptosisinducedbypiroxicampluscisplatincombinedtreatmentistriggeredbyp21inmesothelioma
AT raffaeleacalogero apoptosisinducedbypiroxicampluscisplatincombinedtreatmentistriggeredbyp21inmesothelioma
AT stefaniacrispi apoptosisinducedbypiroxicampluscisplatincombinedtreatmentistriggeredbyp21inmesothelioma
_version_ 1718424373463875584